Focusing on dividend stocks investing and financial independence. Follow the latest news, analysis, rating changes of popular dividend stocks.
March 7, 2016
AbbVie Inc (ABBV) Downgraded to Buy
AbbVie Inc (NASDAQ:ABBV) was downgraded by equities researchers at Goldman Sachs from a “conviction-buy” rating to a “buy” rating in a research note issued to investors on Monday, The Fly reports.
In other news, SVP Timothy J. Richmond sold 12,866 shares of AbbVie stock in a transaction that occurred on Tuesday, March 1st. The shares were sold at an average price of $55.05, for a total transaction of $708,273.30. Following the completion of the sale, the senior vice president now directly owns 79,064 shares in the company, valued at approximately $4,352,473.20. The transaction was disclosed in a legal filing with the SEC,
Source: The Hilltop News.